CASTLE BIOSCIENCES
Castle Biosciences is a biotech company that develops and validates diagnostic tests and technologies for the treatment of cancer. The company also focused on providing physicians and patients with personalized, clinically actionable genomic information to make more accurate treatment plan decisions. The DecisionDx family of molecular diagnostic tests have the ability to meaningfully impact how cancers are diagnosed and managed and the DecisionDx-Melanoma predicts risk of recurrence or metastasis for patients with invasive cutaneous melanoma, a deadly skin cancer, including the risk of sentinel lymph node positivity. Castle Biosciences was founded in 2008 and is headquartered in Friendswood, Texas, United States.
CASTLE BIOSCIENCES
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2008-01-01
Address:
Friendswood, Texas, United States
Country:
United States
Website Url:
http://www.castlebiosciences.com
Total Employee:
251+
Status:
Active
Contact:
602-535-1997
Email Addresses:
[email protected]
Total Funding:
354.27 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Lucira Health
Lucira Health is a biotechnology company that offers disposable test kits to detect RNA and DNA of infectious diseases.
SomaLogic
SomaLogic is a protein biomarker discovery and clinical diagnostics company, offers SOMAmer technology to improve diagnostic products.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-04-04 | AltheaDx | AltheaDx acquired by Castle Biosciences | 65 M USD |
| 2021-10-19 | Cernostics | Cernostics acquired by Castle Biosciences | 30 M USD |
| 2021-04-27 | MyPath Melanoma | MyPath Melanoma acquired by Castle Biosciences | 32.5 M USD |
Investors List
Spindletop Capital Management
Spindletop Capital Management investment in Venture Round - Castle Biosciences
BrightEdge Fund
BrightEdge Fund investment in Convertible Note - Castle Biosciences
MGC Venture Partners
MGC Venture Partners investment in Venture Round - Castle Biosciences
BioBrit
BioBrit investment in Venture Round - Castle Biosciences
Sofinnova Partners
Sofinnova Partners investment in Venture Round - Castle Biosciences
Industry Ventures
Industry Ventures investment in Venture Round - Castle Biosciences
Oxford Finance LLC
Oxford Finance LLC investment in Debt Financing - Castle Biosciences
Silicon Valley Bank
Silicon Valley Bank investment in Debt Financing - Castle Biosciences
Silicon Valley Bank
Silicon Valley Bank investment in Debt Financing - Castle Biosciences
Industry Ventures
Industry Ventures investment in Series F - Castle Biosciences
Official Site Inspections
http://www.castlebiosciences.com Semrush global rank: 1.58 M Semrush visits lastest month: 16.2 K
- Host name: a3ef2d3a3279c65d0.awsglobalaccelerator.com
- IP address: 13.248.192.184
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Castle Biosciences"
About Us | Castle Biosciences
Who we are. We are an innovator in proprietary laboratory-developed tests, which provide personalized, clinically actionable information that can help healthcare providers and patients make more informed disease management decisions.See details»
Castle Biosciences - Crunchbase Company Profile & Funding
Castle Biosciences is a biotech company that develops and validates diagnostic tests and technologies for the treatment of cancer. The company also focused on providing physicians …See details»
Castle Biosciences Inc. - Investor Relations
Nov 4, 2024 [email protected]. Connect With Us. Instagram; Facebook; LinkedIn; X; YouTube; Email Alerts. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert …See details»
Castle Biosciences, Inc. | LinkedIn
Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping ...See details»
Leadership - Castle Biosciences
Meet the innovators and industry-leading professionals behind Castle Biosciences.See details»
Castle Biosciences Inc. - Castle Biosciences’ Chief Operating Officer ...
Jan 9, 2024 Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its Chief Operating Officer, …See details»
Castle Biosciences Expands its Board of Directors with New …
Jul 16, 2021 Investor Contact: Camilla Zuckero 281-906-3868 [email protected] Media Contact: Allison Marshall [email protected] Site Navigation HomeSee details»
Castle Biosciences’ Chief Operating Officer Kristen Oelschlager ...
Jan 9, 2024 Kristen Oelschlager, Castle's COO, has been named to The Healthcare Technology Report’s Top 25 Women Leaders in Biotechnology of 2023.See details»
Castle Biosciences Recognized as a Top 100 Healthcare …
Aug 30, 2021 Investor Contact: Camilla Zuckero 832-835-5158 [email protected] Media Contact: Allison Marshall [email protected] Site Navigation HomeSee details»
Castle Biosciences Inc. - Castle Biosciences’ Chief Operating Officer ...
Sep 16, 2024 The Arizona Bioindustry Association, Inc. (AZBio) and Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, …See details»
Castle Biosciences - Craft
Oct 4, 2024 Castle Biosciences is a company developing and commercializing diagnostic and prognostic tests for dermatologic cancers. It offers products for diagnosing cutaneous …See details»
Castle Biosciences Earns a Top Workplaces USA Award for the …
FRIENDSWOOD, Texas, March 25, 2024--Castle announced it has received a Top Workplaces USA award for the third consecutive year.See details»
Castle Biosciences Earns a Top Workplaces USA Award for the …
Mar 25, 2024 Company honored for creating an exceptional, people-first culture that empowers employees and fosters trust, transparency and authenticity Castle Biosciences, Inc. (Nasdaq: …See details»
Technology - Castle Biosciences
Leveraging advanced technologies for innovative tests. We believe disease management and treatment decisions can be best be informed through a person’s unique biology, which is …See details»
Castle Biosciences Inc. - Castle Biosciences Announces Preliminary ...
Dec 31, 2023 Expect to deliver 2023 total revenue of more than $210 million, at least 53% growth over 2022 Delivered 70,429 total test reports in 2023, an increase of 59% compared to …See details»
Castle Biosciences Ranked Third Among 2023 Top Workplaces in …
Sep 19, 2023 For more information or to nominate your organization, visit energage.com or topworkplaces.com. Contacts Investor Contact: Camilla Zuckero …See details»
Castle Biosciences Inc. - Castle Biosciences Announces Preliminary ...
Dec 31, 2021 2021 Estimated revenue is expected to meet or exceed top end of guided range of $89-93 million Delivered 28,118 gene expression profile test reports in 2021, an increase of …See details»
Castle Biosciences Inc. - Castle Biosciences Earns a Houston …
Nov 19, 2024 Castle also earns national recognition through three additional Top Workplaces Culture Excellence Awards — Employee Appreciation, Employee Well-Being and Professional …See details»
Castle Biosciences Ranked Among the Top Workplaces in Houston …
Nov 13, 2023 For more information or to nominate your organization, visit energage.com or topworkplaces.com. Contacts Investor Contact: Camilla Zuckero …See details»